Radiation Oncology Market Research Report Information by Type (External Beam Radiation Therapy and Internal Radiation Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck, and Others), By End-User (Hospitals & Clinics, Oncology Centers and Academic & Research Institutes) And by Region (North America, Europe, Asia-Pacific, and Rest of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 20

2 MARKET INTRODUCTION 22

2.1 DEFINITION 22

2.2 SCOPE OF THE STUDY 22

2.3 RESEARCH OBJECTIVE 22

2.4 MARKET STRUCTURE 23

3 RESEARCH METHODOLOGY 24

3.1 OVERVIEW 24

3.2 DATA FLOW 25

3.2.1 Data Mining Process 26

3.3 PURCHASED DATABASE: 27

3.4 SECONDARY SOURCES: 28

3.4.1 Secondary Research Data Flow: 29

3.5 PRIMARY RESEARCH: 30

3.5.1 Primary Research DATA FLOW: 31

3.5.2 Primary Research: Number of Interviews conducted 32

3.5.3 Primary Research: Regional Coverage 32

3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 33

3.6.1 Consumption & Net Trade Approach 33

3.6.2 Revenue Analysis Approach 33

3.7 DATA FORECASTING 34

3.7.1 Data Forecasting Technique 34

3.8 DATA MODELING 35

3.8.1 microeconomic factor analysis: 35

3.8.2 Data modeling: 36

3.9 TEAMS AND ANALYST CONTRIBUTION 38

4 MARKET DYNAMICS 39

4.1 INTRODUCTION 39

4.2 DRIVERS 40

4.2.1 Growing incidence of cancer 40

4.2.2 Technological advancements in radiation therapy 41

4.2.3 Rising adoption of combination therapies involving radiation oncology alongside surgery and chemotherapy 41

4.3 CHALLENGES 42

4.3.1 Regulatory approval challanges 42

4.3.2 Reimbursement concerns 43

4.3.3 Lack of skilled radiotherapy professionals 44

4.4 OPPORTUNITY 45

4.4.1 Growing emphasis on value-based healthcare and treatment solutions 45

4.4.2 Rising utilization of artificial intelligence (AI) and machine learning within the field of radiation oncology 45

5 MARKET FACTOR ANALYSIS 47

5.1 VALUE CHAIN ANALYSIS 47

5.1.1 Participants (At different Nodes) 47

5.1.1.1 Raw Material Suppliers 47

5.1.1.2 Manufacturers 48

5.1.1.3 Distribution Channel 48

5.1.1.4 End-user 49

5.1.2 integration levels 49

5.1.3 Key Issues Addressed (Key Success Factors) 50

5.2 PORTER’S FIVE FORCES MODEL 51

5.2.1 Bargaining Power of Suppliers 51

5.2.2 Bargaining Power of Buyers 52

5.2.3 Threat of New Entrants 52

5.2.4 Threat of Substitutes 53

5.2.5 Intensity of Rivalry 54

5.3 IMPACT ANALYSIS OF COVID-19 54

5.3.1 Impact on Overall Healthcare Market 54

5.3.1.1 Economic Impact 55

5.3.2 Impact on Global Radiation Oncology Market 55

5.3.3 Impact on Market Demand 56

5.3.3.1 Impact due to restrictions/lockdown 56

5.3.3.2 Consumer Sentiments 56

5.3.4 Impact on Pricing 56

6 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE 58

6.1 INTRODUCTION 58

6.2 EXTERNAL BEAM RADIATION THERAPY 59

6.2.1 Linear Accelerators (Linac) 60

6.2.1.1 Gamma Knife 61

6.2.1.2 Cyberknife 61

6.2.2 Cobalt-60 System 62

6.2.3 Particle Therapy System 62

6.2.4 Proton Beam Therapy System 63

6.3 INTERNAL RADIATION THERAPY 63

6.3.1 Seeds 64

6.3.2 Afterloaders 64

6.3.3 Intraoperative Radiotherapy Systems 65

7 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION 66

7.1 INTRODUCTION 66

7.2 PROSTATE CANCER 67

7.3 BREAST CANCER 68

7.4 LUNG CANCER 68

7.5 HEAD & NECK 69

7.6 OTHERS 69

8 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER 71

8.1 INTRODUCTION 71

8.2 HOSPITALS & CLINICS 72

8.3 ONCOLOGY CENTERS 72

8.4 ACADEMIC & RESEARCH INSTITUTES 73

9 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION 75

9.1 OVERVIEW 75

9.2 NORTH AMERICA 76

9.2.1 US 81

9.2.2 Canada 83

9.3 EUROPE 85

9.3.1 Germany 90

9.3.2 France 92

9.3.3 UK 94

9.3.4 Italy 96

9.3.5 Spain 98

9.3.6 rest of Europe 100

9.4 ASIA PACIFIC 102

9.4.1 China 106

9.4.2 Japan 108

9.4.3 India 110

9.4.4 South Korea 112

9.4.5 Australia 114

9.4.6 rest of Asia Pacific 116

9.5 REST OF THE WORLD 118

9.5.1 Middle East 123

9.5.2 Africa 125

9.5.3 Latin America 127

10 COMPETITIVE LANDSCAPE 129

10.1 INTRODUCTION 129

10.2 COMPETITION DASHBOARD 129

10.2.1 PRODUCT PORTFOLIO 130

10.2.2 REGIONAL PRESENCE 130

10.2.3 STRATEGIC ALLIANCES 131

10.2.4 INDUSTRY EXPERIENCES 131

10.3 MARKET SHARE ANALYSIS, 2022 131

10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL RADIATION ONCOLOGY MARKET 132

10.5 LIST OF KEY PLAYERS, BY COUNTRY 132

10.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL 133

10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 134

10.7.1 PRODUCT LAUNCH 134

10.7.2 partnership & collaboration 137

10.7.3 Expansion & Acquisition 139

10.7.4 INvestment 140

11 COMPANY PROFILES 141

11.1 VARIAN MEDICAL SYSTEMS, INC. 141

11.1.1 COMPANY OVERVIEW 141

11.1.2 FINANCIAL OVERVIEW 142

11.1.3 PRODUCTS OFFERed 143

11.1.4 KEY DEVELOPMENTS 143

11.1.5 SWOT ANALYSIS 144

11.1.6 Key Strategy 144

11.2 ELEKTA 145

11.2.1 COMPANY OVERVIEW 145

11.2.2 FINANCIAL OVERVIEW 146

11.2.3 PRODUCTS OFFERed 147

11.2.4 KEY DEVELOPMENTS 147

11.2.5 SWOT ANALYSIS 147

11.2.6 Key Strategy 148

11.3 ACCURACY INCORPORATED 148

11.3.1 COMPANY OVERVIEW 148

11.3.2 FINANCIAL OVERVIEW 150

11.3.3 PRODUCTS OFFERed 151

11.3.4 KEY DEVELOPMENTS 151

11.3.5 SWOT ANALYSIS 153

11.3.6 Key Strategy 153

11.4 IBA RADIOPHARMA SOLUTIONS 155

11.4.1 COMPANY OVERVIEW 155

11.4.2 FINANCIAL OVERVIEW 156

11.4.3 PRODUCTS OFFERed 157

11.4.4 KEY DEVELOPMENTS 157

11.4.5 SWOT ANALYSIS 158

11.4.6 Key Strategy 158

11.5 BD 160

11.5.1 COMPANY OVERVIEW 160

11.5.2 FINANCIAL OVERVIEW 161

11.5.3 PRODUCTS OFFERed 162

11.5.4 SWOT ANALYSIS 162

11.5.5 Key Strategy 162

11.6 MEVION MEDICAL SYSTEMS 163

11.6.1 COMPANY OVERVIEW 163

11.6.2 PRODUCTS OFFERed 164

11.6.3 KEY DEVELOPMENTS 164

11.6.4 SWOT ANALYSIS 165

11.6.5 Key Strategy 165

11.7 NORDION 167

11.7.1 COMPANY OVERVIEW 167

11.7.2 FINANCIAL OVERVIEW 168

11.7.3 PRODUCTS OFFERed 168

11.7.4 KEY DEVELOPMENTS 168

11.7.5 SWOT ANALYSIS 168

11.7.6 Key Strategy 169

11.8 NTP RADIOISOTOPES SOC LTD 170

11.8.1 COMPANY OVERVIEW 170

11.8.2 PRODUCTS OFFERed 171

11.8.3 KEY DEVELOPMENTS 171

11.8.4 SWOT ANALYSIS 171

11.8.5 Key Strategy 172

11.9 CURIUM 173

11.9.1 COMPANY OVERVIEW 173

11.9.2 PRODUCTS OFFERed 174

11.9.3 KEY DEVELOPMENTS 174

11.9.4 SWOT ANALYSIS 175

11.9.5 Key Strategy 175

11.10 REFLEXION 176

11.10.1 COMPANY OVERVIEW 176

11.10.2 PRODUCTS OFFERed 177

11.10.3 KEY DEVELOPMENTS 177

11.10.4 SWOT ANALYSIS 177

11.10.5 Key Strategy 178

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 36

TABLE 2 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 59

TABLE 3 GLOBAL RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 60

TABLE 4 GLOBAL RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 61

TABLE 5 GLOBAL RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 64

TABLE 6 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 66

TABLE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 71

TABLE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2019-2032 (USD BILLION) 75

TABLE 9 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 78

TABLE 10 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 78

TABLE 11 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 79

TABLE 12 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 79

TABLE 13 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 79

TABLE 14 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 80

TABLE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 80

TABLE 16 US RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 81

TABLE 17 US RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 81

TABLE 18 US RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 81

TABLE 19 US RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 82

TABLE 20 US RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 82

TABLE 21 US RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 82

TABLE 22 CANADA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 83

TABLE 23 CANADA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 83

TABLE 24 CANADA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 83

TABLE 25 CANADA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 84

TABLE 26 CANADA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 84

TABLE 27 CANADA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 84

TABLE 28 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 87

TABLE 1 EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 88

TABLE 2 EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 88

TABLE 3 EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 88

TABLE 4 EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 89

TABLE 5 EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 89

TABLE 6 EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 89

TABLE 7 GERMANY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 90

TABLE 8 GERMANY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 90

TABLE 9 GERMANY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 90

TABLE 10 GERMANY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 91

TABLE 11 GERMANY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 91

TABLE 12 GERMANY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 91

TABLE 13 FRANCE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 92

TABLE 14 FRANCE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 92

TABLE 15 FRANCE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 92

TABLE 16 FRANCE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 93

TABLE 17 FRANCE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 93

TABLE 18 FRANCE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 93

TABLE 19 UK RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 94

TABLE 20 UK RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 94

TABLE 21 UK RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 94

TABLE 22 UK RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 95

TABLE 23 UK RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 95

TABLE 24 UK RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 95

TABLE 25 ITALY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 96

TABLE 26 ITALY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 96

TABLE 27 ITALY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 96

TABLE 28 ITALY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 97

TABLE 29 ITALY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 97

TABLE 30 ITALY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 97

TABLE 31 SPAIN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 98

TABLE 32 SPAIN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 98

TABLE 33 SPAIN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 98

TABLE 34 SPAIN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 99

TABLE 35 SPAIN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 99

TABLE 36 SPAIN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 99

TABLE 37 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 100

TABLE 38 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 100

TABLE 39 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 100

TABLE 40 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 101

TABLE 41 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 101

TABLE 42 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 101

TABLE 43 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 103

TABLE 44 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 104

TABLE 45 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 104

TABLE 46 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 104

TABLE 47 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 105

TABLE 48 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 105

TABLE 49 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 105

TABLE 50 CHINA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 106

TABLE 51 CHINA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 106

TABLE 52 CHINA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 106

TABLE 53 CHINA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 107

TABLE 54 CHINA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 107

TABLE 55 CHINA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 107

TABLE 56 JAPAN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 108

TABLE 57 JAPAN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 108

TABLE 58 JAPAN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 108

TABLE 59 JAPAN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 109

TABLE 60 JAPAN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 109

TABLE 61 JAPAN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 109

TABLE 62 INDIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 110

TABLE 63 INDIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 110

TABLE 64 INDIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 110

TABLE 65 INDIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 111

TABLE 66 INDIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 111

TABLE 67 INDIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 111

TABLE 68 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 112

TABLE 69 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 112

TABLE 70 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 112

TABLE 71 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 113

TABLE 72 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 113

TABLE 73 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 113

TABLE 74 AUSTRALIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 114

TABLE 75 AUSTRALIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 114

TABLE 76 AUSTRALIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 114

TABLE 77 AUSTRALIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 115

TABLE 78 AUSTRALIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 115

TABLE 79 AUSTRALIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 115

TABLE 80 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 116

TABLE 81 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 116

TABLE 82 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 116

TABLE 83 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 117

TABLE 84 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 117

TABLE 85 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 117

TABLE 86 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION) 120

TABLE 87 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 121

TABLE 88 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 121

TABLE 89 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 121

TABLE 90 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 122

TABLE 91 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 122

TABLE 92 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 122

TABLE 93 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 123

TABLE 94 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 123

TABLE 95 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 123

TABLE 96 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 124

TABLE 97 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 124

TABLE 98 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 124

TABLE 99 AFRICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 125

TABLE 100 AFRICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 125

TABLE 101 AFRICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 125

TABLE 102 AFRICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 126

TABLE 103 AFRICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 126

TABLE 104 AFRICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 126

TABLE 105 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION) 127

TABLE 106 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION) 127

TABLE 107 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION) 127

TABLE 108 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION) 128

TABLE 109 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION) 128

TABLE 110 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION) 128

TABLE 111 PRODUCT LAUNCH 134

TABLE 112 PARTNERSHIP & COLLABORATION 137

TABLE 113 EXPANSION & ACQUISITION 139

TABLE 114 INSTRUMENT 140

TABLE 115 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 143

TABLE 116 ELEKTA: PRODUCTS OFFERED 147

TABLE 117 ACCURACY INCORPORATED: PRODUCTS OFFERED 151

TABLE 118 ACCURACY INCORPORATED: KEY DEVELOPMENTS 151

TABLE 119 IBA RADIOPHARMA SOLUTIONS: PRODUCTS OFFERED 157

TABLE 120 IBA RADIOPHARMA SOLUTIONS: KEY DEVELOPMENTS 157

TABLE 121 BD: PRODUCTS OFFERED 162

TABLE 122 MEVION MEDICAL SYSTEMS: PRODUCTS OFFERED 164

TABLE 123 MEVION MEDICAL SYSTEMS: KEY DEVELOPMENTS 164

TABLE 124 NORDION: PRODUCTS OFFERED 168

TABLE 125 NTP RADIOISOTOPES SOC LTD: PRODUCTS OFFERED 171

TABLE 126 CURIUM: PRODUCTS OFFERED 174

TABLE 127 REFLEXION: PRODUCTS OFFERED 177

LIST OF FIGURES

FIGURE 1 GLOBAL RADIATION ONCOLOGY MARKET: STRUCTURE 23

FIGURE 2 GLOBAL RADIATION ONCOLOGY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 39

FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 42

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 44

FIGURE 5 SUPPLY CHAIN ANALYSIS: GLOBAL RADIATION ONCOLOGY MARKET 47

FIGURE 6 PORTER’S FIVE FORCES MODEL: GLOBAL RADIATION ONCOLOGY MARKET 51

FIGURE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, SEGMENT ATTRACTIVENESS ANALYSIS 58

FIGURE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2022 (% SHARE) 59

FIGURE 9 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS 66

FIGURE 10 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2022 (% SHARE) 67

FIGURE 11 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS 71

FIGURE 12 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2022 (% SHARE) 72

FIGURE 13 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2022 (% SHARE) 75

FIGURE 14 NORTH AMERICA MARKET: SWOT ANALYSIS 77

FIGURE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 78

FIGURE 16 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 86

FIGURE 17 EUROPE MARKET: SWOT ANALYSIS 87

FIGURE 18 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 102

FIGURE 19 ASIA PACIFIC MARKET: SWOT ANALYSIS 103

FIGURE 20 ROW RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE) 119

FIGURE 21 REST OF THE WORLD MARKET: SWOT ANALYSIS 120

FIGURE 22 COMPETITOR DASHBOARD: GLOBAL RADIATION ONCOLOGY MARKET 130

FIGURE 23 GLOBAL RADIATION ONCOLOGY MARKET: COMPETITIVE ANALYSIS, 2022 131

FIGURE 24 VARIAN MEDICAL SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT 142

FIGURE 25 VARIAN MEDICAL SYSTEMS, INC.: SWOT ANALYSIS 144

FIGURE 26 ELEKTA: SWOT ANALYSIS 147

FIGURE 27 ACCURACY INCORPORATED: SWOT ANALYSIS 153

FIGURE 28 IBA RADIOPHARMA SOLUTIONS: SWOT ANALYSIS 158

FIGURE 29 BD: SWOT ANALYSIS 162

FIGURE 30 MEVION MEDICAL SYSTEMS: SWOT ANALYSIS 165

FIGURE 31 NORDION: SWOT ANALYSIS 168

FIGURE 32 NTP RADIOISOTOPES SOC LTD: SWOT ANALYSIS 171

FIGURE 33 CURIUM: SWOT ANALYSIS 175

FIGURE 34 REFLEXION: SWOT ANALYSIS 177